Innovation

Measurements of Brain Plasticity for Neurodevelopmental Disorders such as Autism Spectrum Disorders or Schizophrenia (BIDMC 1268)

Beth Israel Deaconess Medical Center
posted on 11/25/2011

Peptide, Phosphopeptide, peptidomemitic inhibitors of Pin1 & methods of inhibiting Pin1 to treat cancer

See Pin1 Portfolio on TVO Available Technologies website for more information.


Innovation Details
 

File Number: 793 

Other Information:

Investigator(s)
Dr. Alvaro Pascual-Leone

Contact
Stanley, Mah C


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Abi Barrow at Beth Israel Deaconess Medical Center for more information.

Request more info via email request more info
People

Case Manager:

Abi Barrow Abi Barrow

Innovations (0)

Download Technology Brief (PDF)


[?]
Followed By

Follow this innovation



No one is following this innovation.

Organization
3428

Beth Israel Deaconess Medical Center


Communities
Profile
Related Tags

Find more innovations

February 11, 2009

10,984 members 18,005 innovations 172 organizations

Browse

William Garner, M.D., MPH - CEO of Urigen, N.A., Inc.

"The iBridge Network provides an important additional pathway for entrepreneurs to access university innovations that may otherwise have been lost. The transparency of this pathway between entrepreneurs..."  read more...